Cathine
Clinical data | |
---|---|
Routes of administration |
Oral |
ATC code | A08AA07 (WHO) |
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Biological half-life | 1.8-8.6 h[1] |
Identifiers | |
|
|
CAS Number | 492-39-7 |
PubChem (CID) | 441457 |
DrugBank | DB01486 |
ChemSpider | 390189 |
UNII | E1L4ZW2F8O |
ChEMBL | CHEMBL1412041 |
ECHA InfoCard | 100.007.050 |
Chemical and physical data | |
Formula | C9H13NO |
Molar mass | 151.206 g/mol |
3D model (Jmol) | Interactive image |
|
|
|
|
(what is this?) (verify) |
Cathine, also known as d-norpseudoephedrine and (+)-norpseudoephedrine, is a psychoactive drug of the phenethylamine and amphetamine chemical classes which acts as a stimulant. Along with cathinone, it is found naturally in Catha edulis (khat), and contributes to its overall effects.[2] It has approximately 10-14% the potency of amphetamine.[2]
Pharmacology[edit]
Like amphetamines, cathinone, and ephedrine, cathine acts as a norepinephrine releasing agent (NRA).[2] It also acts as a dopamine releasing agent (DRA) to a lesser extent.[2]
Chemistry[edit]
Cathine is one of the four stereoisomers of phenylpropanolamine (PPA).
Regulation[edit]
The World Anti-Doping Agency's list of prohibited substances (used for the Olympic Games among other athletic events) bars cathine in concentrations of over 5 micrograms per milliliter in urine. Cathine is a Schedule III drug under the Convention on Psychotropic Substances.[3] In the United States, it is classified as a Schedule IV controlled substance.
In Australia, Cathine is officially a schedule 4 drug but is not yet available or approved for any use.
In Hong Kong, cathine is regulated under Schedule 1 of Hong Kong's Chapter 134 Dangerous Drugs Ordinance. Unlawful possession is punishable by severe fines and imprisonment.
See also[edit]
- L-Norpseudoephedrine, an enantiomer
- Phenylpropanolamine
- Catha edulis ("Khat")
- Cathinone
- Methcathinone
- Ephedra sinica ("Ephedra")
- Ephedrine
- Pseudoephedrine
- Phenethylamine
- Amphetamine
- Methamphetamine
References[edit]
- ^ Toennes SW, Harder S, Schramm M, Niess C, Kauert GF (2003). "Pharmacokinetics of cathinone, cathine and norephedrine after the chewing of khat leaves". Br J Clin Pharmacol. 56 (1): 125–130. doi:10.1046/j.1365-2125.2003.01834.x. PMC 1884326. PMID 12848785.
- ^ a b c d Hoffman, R; Al'Absi, M (December 2010). "Khat use and neurobehavioral functions: suggestions for future studies." (PDF). Journal of Ethnopharmacology. 132 (3): 554–63. doi:10.1016/j.jep.2010.05.033. PMC 2976806. PMID 20553832.
- ^ "List of psychotropic substances under international control" (PDF). International Narcotics Control Board. Archived from the original (PDF) on 2012-08-31.